Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR
Treatment-resistant schizophrenia (TRS) has a quite complex pathophysiology that includes not only severe positive symptoms but also other symptom domains. Much attention has been devoted to the overlapping psychological and biological profiles of schizophrenia and autistic spectrum disorder (ASD)....
Gespeichert in:
Veröffentlicht in: | Journal of psychiatric research 2021-06, Vol.138, p.219-227 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 227 |
---|---|
container_issue | |
container_start_page | 219 |
container_title | Journal of psychiatric research |
container_volume | 138 |
creator | Nakata, Yusuke Kanahara, Nobuhisa Kimura, Atsushi Niitsu, Tomihisa Komatsu, Hideki Oda, Yasunori Nakamura, Miwako Ishikawa, Masatomo Hasegawa, Tadashi Kamata, Yu Yamauchi, Atsushi Inazumi, Kazuhiko Kimura, Hiroshi Shiko, Yuki Kawasaki, Yohei Iyo, Masaomi |
description | Treatment-resistant schizophrenia (TRS) has a quite complex pathophysiology that includes not only severe positive symptoms but also other symptom domains. Much attention has been devoted to the overlapping psychological and biological profiles of schizophrenia and autistic spectrum disorder (ASD). We compared TRS patients (n = 30) with schizophrenia patients in remission (RemSZ, n = 28) and ASD patients (n = 28), focusing on general cognitive and social cognitive impairment and oxytocin system dysfunction. Our analyses revealed that there was no difference in oxytocin concentration among the three groups. The TRS patients’ oxytocin blood concentrations were positively correlated with their processing speed and theory-of-mind scores, whereas the RemSZ and ASD groups had no significant relation with any measures. Rs53576, a single nucleotide polymorphism on the oxytocin receptor gene, affected social cognition abilities in the schizophrenia group. Although the overall findings are preliminary, they indicate that oxytocin system dysfunction could be involved in the serious cognitive deficits in TRS patients. Further, these results suggest that patients with TRS might have early neurodevelopmental abnormalities based on their shared biological features with ASD patients.
•・Oxytocin system abnormalities were implicated in the etiologies of psychiatric disorders such as autistic spectrum disorder (ASD) and schizophrenia. Although this system has been considered to be related to several symptom domains of these disorders, it is uncertain how and why oxytocin is involved in multiple psychopathologies.•・The present study measured the serum concentrations of oxytocin and sequenced the OXTR gene for the two schizophrenia group (treatment-resistant schizophrenia (TRS), n = 30; remission schizophrenia (RemSZ), n = 28) and the ASD group (n = 28).•・The blood concentration of oxytocin was positively correlated with process of speed in general cognitive measurements and theory-of-mind in social cognitive measurement in the TRS group. However, any relationship between oxytocin concentration and general/cognitive domains was not observed in the RemSZ and ASD group.•・G allele carriers of rs53576, an intronic SNP on the OXTR gene, in the schizophrenia group were worse in theory-of-mind score to non-G allele carriers.•・These findings suggest that oxytocin system dysfunction could affect profoundly treatment-refractory symptoms through mediating social cognitive process in pati |
doi_str_mv | 10.1016/j.jpsychires.2021.03.053 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2515063969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022395621002053</els_id><sourcerecordid>2515063969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-ee0399288c4128f038a445900f0872697b952e796da2cb2503a95ec2a20faba13</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EokvhLyAfuSQd2-sk5lYqoEiVVkJF4mY5zoT1KomD7V0Iv4Ufi6Nt4cjJ8uh7743mEUIZlAxYdXUoD3Nc7N4FjCUHzkoQJUjxhGxYU6uCiVo9JRsAzguhZHVBXsR4AICas-1zciFEU1UgYUN-734uyVs30bjEhCPtltgfJ5ucn2ieziY5nFKkP1za0xTQpDH_ixzsYjJTojGv8cvP-4CTM2_p9ZAwmFUeqe9pO3jfUf8YMuAJh0jN1FHse7RpZQz9hhMmZ-nJBLd65uHu6_3nl-RZb4aIrx7eS_Llw_v7m9vibvfx0831XWF5o1KBCEIp3jR2y3jTg2jMdisVQA9NzStVt0pyrFXVGW5bLkEYJdFyw6E3rWHikrw5-87Bfz9iTHp00eIwmAn9MWoumYRKqEpltDmjNvgYA_Z6Dm40YdEM9NqNPuh_3ei1Gw1C526y9PVDyrEdsfsrfCwjA-_OQD4RnhwGHW0-vsUue9mkO-_-n_IHsaOpHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2515063969</pqid></control><display><type>article</type><title>Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Nakata, Yusuke ; Kanahara, Nobuhisa ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Oda, Yasunori ; Nakamura, Miwako ; Ishikawa, Masatomo ; Hasegawa, Tadashi ; Kamata, Yu ; Yamauchi, Atsushi ; Inazumi, Kazuhiko ; Kimura, Hiroshi ; Shiko, Yuki ; Kawasaki, Yohei ; Iyo, Masaomi</creator><creatorcontrib>Nakata, Yusuke ; Kanahara, Nobuhisa ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Oda, Yasunori ; Nakamura, Miwako ; Ishikawa, Masatomo ; Hasegawa, Tadashi ; Kamata, Yu ; Yamauchi, Atsushi ; Inazumi, Kazuhiko ; Kimura, Hiroshi ; Shiko, Yuki ; Kawasaki, Yohei ; Iyo, Masaomi</creatorcontrib><description>Treatment-resistant schizophrenia (TRS) has a quite complex pathophysiology that includes not only severe positive symptoms but also other symptom domains. Much attention has been devoted to the overlapping psychological and biological profiles of schizophrenia and autistic spectrum disorder (ASD). We compared TRS patients (n = 30) with schizophrenia patients in remission (RemSZ, n = 28) and ASD patients (n = 28), focusing on general cognitive and social cognitive impairment and oxytocin system dysfunction. Our analyses revealed that there was no difference in oxytocin concentration among the three groups. The TRS patients’ oxytocin blood concentrations were positively correlated with their processing speed and theory-of-mind scores, whereas the RemSZ and ASD groups had no significant relation with any measures. Rs53576, a single nucleotide polymorphism on the oxytocin receptor gene, affected social cognition abilities in the schizophrenia group. Although the overall findings are preliminary, they indicate that oxytocin system dysfunction could be involved in the serious cognitive deficits in TRS patients. Further, these results suggest that patients with TRS might have early neurodevelopmental abnormalities based on their shared biological features with ASD patients.
•・Oxytocin system abnormalities were implicated in the etiologies of psychiatric disorders such as autistic spectrum disorder (ASD) and schizophrenia. Although this system has been considered to be related to several symptom domains of these disorders, it is uncertain how and why oxytocin is involved in multiple psychopathologies.•・The present study measured the serum concentrations of oxytocin and sequenced the OXTR gene for the two schizophrenia group (treatment-resistant schizophrenia (TRS), n = 30; remission schizophrenia (RemSZ), n = 28) and the ASD group (n = 28).•・The blood concentration of oxytocin was positively correlated with process of speed in general cognitive measurements and theory-of-mind in social cognitive measurement in the TRS group. However, any relationship between oxytocin concentration and general/cognitive domains was not observed in the RemSZ and ASD group.•・G allele carriers of rs53576, an intronic SNP on the OXTR gene, in the schizophrenia group were worse in theory-of-mind score to non-G allele carriers.•・These findings suggest that oxytocin system dysfunction could affect profoundly treatment-refractory symptoms through mediating social cognitive process in patients with schizophrenia.</description><identifier>ISSN: 0022-3956</identifier><identifier>EISSN: 1879-1379</identifier><identifier>DOI: 10.1016/j.jpsychires.2021.03.053</identifier><identifier>PMID: 33866050</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Autism Spectrum Disorder - genetics ; Autistic spectrum disorder ; Humans ; Oxytocin - genetics ; Oxytocin receptor ; Polymorphism, Single Nucleotide - genetics ; Receptors, Oxytocin - genetics ; Remission ; Schizophrenia - drug therapy ; Schizophrenia - genetics ; Social cognition ; Theory of mind</subject><ispartof>Journal of psychiatric research, 2021-06, Vol.138, p.219-227</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c289t-ee0399288c4128f038a445900f0872697b952e796da2cb2503a95ec2a20faba13</citedby><cites>FETCH-LOGICAL-c289t-ee0399288c4128f038a445900f0872697b952e796da2cb2503a95ec2a20faba13</cites><orcidid>0000-0001-8550-8003</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpsychires.2021.03.053$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33866050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakata, Yusuke</creatorcontrib><creatorcontrib>Kanahara, Nobuhisa</creatorcontrib><creatorcontrib>Kimura, Atsushi</creatorcontrib><creatorcontrib>Niitsu, Tomihisa</creatorcontrib><creatorcontrib>Komatsu, Hideki</creatorcontrib><creatorcontrib>Oda, Yasunori</creatorcontrib><creatorcontrib>Nakamura, Miwako</creatorcontrib><creatorcontrib>Ishikawa, Masatomo</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Kamata, Yu</creatorcontrib><creatorcontrib>Yamauchi, Atsushi</creatorcontrib><creatorcontrib>Inazumi, Kazuhiko</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shiko, Yuki</creatorcontrib><creatorcontrib>Kawasaki, Yohei</creatorcontrib><creatorcontrib>Iyo, Masaomi</creatorcontrib><title>Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR</title><title>Journal of psychiatric research</title><addtitle>J Psychiatr Res</addtitle><description>Treatment-resistant schizophrenia (TRS) has a quite complex pathophysiology that includes not only severe positive symptoms but also other symptom domains. Much attention has been devoted to the overlapping psychological and biological profiles of schizophrenia and autistic spectrum disorder (ASD). We compared TRS patients (n = 30) with schizophrenia patients in remission (RemSZ, n = 28) and ASD patients (n = 28), focusing on general cognitive and social cognitive impairment and oxytocin system dysfunction. Our analyses revealed that there was no difference in oxytocin concentration among the three groups. The TRS patients’ oxytocin blood concentrations were positively correlated with their processing speed and theory-of-mind scores, whereas the RemSZ and ASD groups had no significant relation with any measures. Rs53576, a single nucleotide polymorphism on the oxytocin receptor gene, affected social cognition abilities in the schizophrenia group. Although the overall findings are preliminary, they indicate that oxytocin system dysfunction could be involved in the serious cognitive deficits in TRS patients. Further, these results suggest that patients with TRS might have early neurodevelopmental abnormalities based on their shared biological features with ASD patients.
•・Oxytocin system abnormalities were implicated in the etiologies of psychiatric disorders such as autistic spectrum disorder (ASD) and schizophrenia. Although this system has been considered to be related to several symptom domains of these disorders, it is uncertain how and why oxytocin is involved in multiple psychopathologies.•・The present study measured the serum concentrations of oxytocin and sequenced the OXTR gene for the two schizophrenia group (treatment-resistant schizophrenia (TRS), n = 30; remission schizophrenia (RemSZ), n = 28) and the ASD group (n = 28).•・The blood concentration of oxytocin was positively correlated with process of speed in general cognitive measurements and theory-of-mind in social cognitive measurement in the TRS group. However, any relationship between oxytocin concentration and general/cognitive domains was not observed in the RemSZ and ASD group.•・G allele carriers of rs53576, an intronic SNP on the OXTR gene, in the schizophrenia group were worse in theory-of-mind score to non-G allele carriers.•・These findings suggest that oxytocin system dysfunction could affect profoundly treatment-refractory symptoms through mediating social cognitive process in patients with schizophrenia.</description><subject>Autism Spectrum Disorder - genetics</subject><subject>Autistic spectrum disorder</subject><subject>Humans</subject><subject>Oxytocin - genetics</subject><subject>Oxytocin receptor</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Receptors, Oxytocin - genetics</subject><subject>Remission</subject><subject>Schizophrenia - drug therapy</subject><subject>Schizophrenia - genetics</subject><subject>Social cognition</subject><subject>Theory of mind</subject><issn>0022-3956</issn><issn>1879-1379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EokvhLyAfuSQd2-sk5lYqoEiVVkJF4mY5zoT1KomD7V0Iv4Ufi6Nt4cjJ8uh7743mEUIZlAxYdXUoD3Nc7N4FjCUHzkoQJUjxhGxYU6uCiVo9JRsAzguhZHVBXsR4AICas-1zciFEU1UgYUN-734uyVs30bjEhCPtltgfJ5ucn2ieziY5nFKkP1za0xTQpDH_ixzsYjJTojGv8cvP-4CTM2_p9ZAwmFUeqe9pO3jfUf8YMuAJh0jN1FHse7RpZQz9hhMmZ-nJBLd65uHu6_3nl-RZb4aIrx7eS_Llw_v7m9vibvfx0831XWF5o1KBCEIp3jR2y3jTg2jMdisVQA9NzStVt0pyrFXVGW5bLkEYJdFyw6E3rWHikrw5-87Bfz9iTHp00eIwmAn9MWoumYRKqEpltDmjNvgYA_Z6Dm40YdEM9NqNPuh_3ei1Gw1C526y9PVDyrEdsfsrfCwjA-_OQD4RnhwGHW0-vsUue9mkO-_-n_IHsaOpHA</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Nakata, Yusuke</creator><creator>Kanahara, Nobuhisa</creator><creator>Kimura, Atsushi</creator><creator>Niitsu, Tomihisa</creator><creator>Komatsu, Hideki</creator><creator>Oda, Yasunori</creator><creator>Nakamura, Miwako</creator><creator>Ishikawa, Masatomo</creator><creator>Hasegawa, Tadashi</creator><creator>Kamata, Yu</creator><creator>Yamauchi, Atsushi</creator><creator>Inazumi, Kazuhiko</creator><creator>Kimura, Hiroshi</creator><creator>Shiko, Yuki</creator><creator>Kawasaki, Yohei</creator><creator>Iyo, Masaomi</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8550-8003</orcidid></search><sort><creationdate>202106</creationdate><title>Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR</title><author>Nakata, Yusuke ; Kanahara, Nobuhisa ; Kimura, Atsushi ; Niitsu, Tomihisa ; Komatsu, Hideki ; Oda, Yasunori ; Nakamura, Miwako ; Ishikawa, Masatomo ; Hasegawa, Tadashi ; Kamata, Yu ; Yamauchi, Atsushi ; Inazumi, Kazuhiko ; Kimura, Hiroshi ; Shiko, Yuki ; Kawasaki, Yohei ; Iyo, Masaomi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-ee0399288c4128f038a445900f0872697b952e796da2cb2503a95ec2a20faba13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Autism Spectrum Disorder - genetics</topic><topic>Autistic spectrum disorder</topic><topic>Humans</topic><topic>Oxytocin - genetics</topic><topic>Oxytocin receptor</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Receptors, Oxytocin - genetics</topic><topic>Remission</topic><topic>Schizophrenia - drug therapy</topic><topic>Schizophrenia - genetics</topic><topic>Social cognition</topic><topic>Theory of mind</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakata, Yusuke</creatorcontrib><creatorcontrib>Kanahara, Nobuhisa</creatorcontrib><creatorcontrib>Kimura, Atsushi</creatorcontrib><creatorcontrib>Niitsu, Tomihisa</creatorcontrib><creatorcontrib>Komatsu, Hideki</creatorcontrib><creatorcontrib>Oda, Yasunori</creatorcontrib><creatorcontrib>Nakamura, Miwako</creatorcontrib><creatorcontrib>Ishikawa, Masatomo</creatorcontrib><creatorcontrib>Hasegawa, Tadashi</creatorcontrib><creatorcontrib>Kamata, Yu</creatorcontrib><creatorcontrib>Yamauchi, Atsushi</creatorcontrib><creatorcontrib>Inazumi, Kazuhiko</creatorcontrib><creatorcontrib>Kimura, Hiroshi</creatorcontrib><creatorcontrib>Shiko, Yuki</creatorcontrib><creatorcontrib>Kawasaki, Yohei</creatorcontrib><creatorcontrib>Iyo, Masaomi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychiatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakata, Yusuke</au><au>Kanahara, Nobuhisa</au><au>Kimura, Atsushi</au><au>Niitsu, Tomihisa</au><au>Komatsu, Hideki</au><au>Oda, Yasunori</au><au>Nakamura, Miwako</au><au>Ishikawa, Masatomo</au><au>Hasegawa, Tadashi</au><au>Kamata, Yu</au><au>Yamauchi, Atsushi</au><au>Inazumi, Kazuhiko</au><au>Kimura, Hiroshi</au><au>Shiko, Yuki</au><au>Kawasaki, Yohei</au><au>Iyo, Masaomi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR</atitle><jtitle>Journal of psychiatric research</jtitle><addtitle>J Psychiatr Res</addtitle><date>2021-06</date><risdate>2021</risdate><volume>138</volume><spage>219</spage><epage>227</epage><pages>219-227</pages><issn>0022-3956</issn><eissn>1879-1379</eissn><abstract>Treatment-resistant schizophrenia (TRS) has a quite complex pathophysiology that includes not only severe positive symptoms but also other symptom domains. Much attention has been devoted to the overlapping psychological and biological profiles of schizophrenia and autistic spectrum disorder (ASD). We compared TRS patients (n = 30) with schizophrenia patients in remission (RemSZ, n = 28) and ASD patients (n = 28), focusing on general cognitive and social cognitive impairment and oxytocin system dysfunction. Our analyses revealed that there was no difference in oxytocin concentration among the three groups. The TRS patients’ oxytocin blood concentrations were positively correlated with their processing speed and theory-of-mind scores, whereas the RemSZ and ASD groups had no significant relation with any measures. Rs53576, a single nucleotide polymorphism on the oxytocin receptor gene, affected social cognition abilities in the schizophrenia group. Although the overall findings are preliminary, they indicate that oxytocin system dysfunction could be involved in the serious cognitive deficits in TRS patients. Further, these results suggest that patients with TRS might have early neurodevelopmental abnormalities based on their shared biological features with ASD patients.
•・Oxytocin system abnormalities were implicated in the etiologies of psychiatric disorders such as autistic spectrum disorder (ASD) and schizophrenia. Although this system has been considered to be related to several symptom domains of these disorders, it is uncertain how and why oxytocin is involved in multiple psychopathologies.•・The present study measured the serum concentrations of oxytocin and sequenced the OXTR gene for the two schizophrenia group (treatment-resistant schizophrenia (TRS), n = 30; remission schizophrenia (RemSZ), n = 28) and the ASD group (n = 28).•・The blood concentration of oxytocin was positively correlated with process of speed in general cognitive measurements and theory-of-mind in social cognitive measurement in the TRS group. However, any relationship between oxytocin concentration and general/cognitive domains was not observed in the RemSZ and ASD group.•・G allele carriers of rs53576, an intronic SNP on the OXTR gene, in the schizophrenia group were worse in theory-of-mind score to non-G allele carriers.•・These findings suggest that oxytocin system dysfunction could affect profoundly treatment-refractory symptoms through mediating social cognitive process in patients with schizophrenia.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33866050</pmid><doi>10.1016/j.jpsychires.2021.03.053</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-8550-8003</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3956 |
ispartof | Journal of psychiatric research, 2021-06, Vol.138, p.219-227 |
issn | 0022-3956 1879-1379 |
language | eng |
recordid | cdi_proquest_miscellaneous_2515063969 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Autism Spectrum Disorder - genetics Autistic spectrum disorder Humans Oxytocin - genetics Oxytocin receptor Polymorphism, Single Nucleotide - genetics Receptors, Oxytocin - genetics Remission Schizophrenia - drug therapy Schizophrenia - genetics Social cognition Theory of mind |
title | Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T10%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxytocin%20system%20dysfunction%20in%20patients%20with%20treatment-resistant%20schizophrenia:%20Alterations%20of%20blood%20oxytocin%20levels%20and%20effect%20of%20a%20genetic%20variant%20of%20OXTR&rft.jtitle=Journal%20of%20psychiatric%20research&rft.au=Nakata,%20Yusuke&rft.date=2021-06&rft.volume=138&rft.spage=219&rft.epage=227&rft.pages=219-227&rft.issn=0022-3956&rft.eissn=1879-1379&rft_id=info:doi/10.1016/j.jpsychires.2021.03.053&rft_dat=%3Cproquest_cross%3E2515063969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2515063969&rft_id=info:pmid/33866050&rft_els_id=S0022395621002053&rfr_iscdi=true |